The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Inhibition of Alzheimer β-Fibrillogenesis by Melatonin
Open accessAbstract
It is generally postulated that the amyloid beta protein (Abeta) plays a central role in the progressive neurodegeneration observed in Alzheimer's disease. Important pathologic properties of this protein, such as neurotoxicity and resistance to proteolytic degradation, depend on the ability of Abeta to form beta-sheet structures or amyloid fibrils. We report that melatonin, a hormone recently found to protect neurons against Abeta toxicity, interacts with Abeta1-40 and Abeta1-42 and inhibits the progressive formation of beta-sheets and amyloid fibrils. These interactions between melatonin and the amyloid peptides were demonstrated by circular dichroism and electron microscopy for Abeta1-40 and Abeta1-42 and by nuclear magnetic resonance spectroscopy for Abeta1-40. Inhibition of beta-sheets and fibrils could not be accomplished in control experiments when a free radical scavenger or a melatonin analog were substituted for melatonin under otherwise identical conditions. In sharp contrast with conventional anti-oxidants and available anti-amyloidogenic compounds, melatonin crosses the blood-brain barrier, is relatively devoid of toxicity, and constitutes a potential new therapeutic agent in Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Computed circular dichroism spectra for the evaluation of protein conformation
Greenfield, N. J., & Fasman, G. D. (1969) · Biochemistry · doi:10.1021/bi00838a031 · Cited by 3,694
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
Jarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731
Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing
Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., et al. (1992) · Science · doi:10.1126/science.1439760 · Cited by 1,447
Self-citationNeurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324
Lantos, P. (1985) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.48.5.496 · Cited by 1,152
Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.
Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., & Glabe, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48529-8 · Cited by 1,014
Pike, C. J., Walencewicz‐Wasserman, A. J., Kosmoski, J., Cribbs, D. H., Glabe, C. G., & Cotman, C. W. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64010253.x · Cited by 699
Amyloid β Protein (Aβ) in Alzheimeri's Disease Brain
Gravina, S. A., Ho, L., Eckman, C. B., Long, K. E., Otvos, L., Younkin, L. H., Suzuki, N., & Younkin, S. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7013 · Cited by 676
Barrow, C. J., Yasuda, A., Kenny, P. T. M., & Zagorski, M. G. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90106-t · Cited by 635
Self-citationAggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease
Hilbich, C., Kisters-Woike, B., Reed, J., Masters, C. L., & Beyreuther, K. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90881-6 · Cited by 580
Solution Structures of β Peptide and Its Constituent Fragments: Relation to Amyloid Deposition
Barrow, C. J., & Zagorski, M. G. (1991) · Science · doi:10.1126/science.1853202 · Cited by 537
Self-citation(1997) · doi:10.1073/pnas.94.4.1550 · Cited by 535
Kirschner, D. A., Inouye, H., Duffy, L. K., Sinclair, A., Lind, M., & Selkoe, D. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6953 · Cited by 482
Perczel, A., Park, K., & Fasman, G. D. (1992) · Analytical Biochemistry · doi:10.1016/0003-2697(92)90046-a · Cited by 430
Transthyretin sequesters amyloid beta protein and prevents amyloid formation.
Schwarzman, A. L., Gregori, L., Vitek, M. P., Lyubski, S., Strittmatter, W. J., Enghilde, J. J., Bhasin, R., Silverman, J., Weisgraber, K. H., & Coyle, P. K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8368 · Cited by 413
Snyder, S. W., Ladror, U. S., Wade, W. S., Wang, G. T., Barrett, L. W., Matayoshi, E. D., Huffaker, H. J., Krafft, G. A., & Holzman, T. F. (1994) · Biophysical Journal · doi:10.1016/s0006-3495(94)80591-0 · Cited by 381
Age-Dependent Reduction in Serum Melatonin Concentrations in Healthy Human Subjects
IGUCHI, H., KATO, K.-I., & IBAYASHI, H. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-1-27 · Cited by 379
pH-dependent structural transitions of Alzheimer amyloid peptides
Fraser, P. E., Nguyen, J. T., Surewicz, W. K., & Kirschner, D. A. (1991) · Biophysical Journal · doi:10.1016/s0006-3495(91)82154-3 · Cited by 376
Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro.
Simmons, L. K., May, P. C., Tomaselli, K. J., Rydel, R. E., Fuson, K. S., Brigham, E. F., Wright, S., Lieberburg, I., Becker, G. W., & Brems, D. N. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10007-2 · Cited by 371
Melatonin Prevents Death of Neuroblastoma Cells Exposed to the Alzheimer Amyloid Peptide
Pappolla, M. A., Sos, M., Omar, R. A., Bick, R. J., Hickson-Bick, D. L. M., Reiter, R. J., Efthimiopoulos, S., & Robakis, N. K. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-05-01683.1997 · Cited by 359
Dyrks, T., Dyrks, E., Hartmann, T., Masters, C., & Beyreuther, K. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37174-1 · Cited by 343
Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia
Mishima, K., Okawa, M., Hishikawa, Y., Hozumi, S., Hori, H., & Takahashi, K. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb01477.x · Cited by 334
Harris, M. E., Hensley, K., Butterfield, D. A., Leedle, R. A., & Carney, J. M. (1995) · Experimental Neurology · doi:10.1016/0014-4886(95)90041-1 · Cited by 332
Modulation of A beta adhesiveness and secretase site cleavage by zinc.
Bush, A. I., Pettingell, W. H., Paradis, M. D., & Tanzi, R. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32694-7 · Cited by 331
Self-association of β-Amyloid Peptide (1–40) in Solution and Binding to Lipid Membranes
Terzi, E., Hölzemann, G., & Seelig, J. (1995) · Journal of Molecular Biology · doi:10.1006/jmbi.1995.0525 · Cited by 306
Solvent effects on self-assembly of beta-amyloid peptide
Shen, C. L., & Murphy, R. M. (1995) · Biophysical Journal · doi:10.1016/s0006-3495(95)79940-4 · Cited by 277
First-order kinetic model of Alzheimer's beta-amyloid fibril extension in vitro.
Naiki, H., & Nakakuki, K. (1996) · PubMed · Cited by 244
The Effects of Oral Melatonin on Skin Color and on the Release of Pituitary Hormones
NORDLUND, J. J., & LERNER, A. B. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-45-4-768 · Cited by 227
Nicotine Inhibits Amyloid Formation by the β-Peptide
Salomon, A. R., Marcinowski, K. J., Friedland, R. P., & Zagorski, M. G. (1996) · Biochemistry · doi:10.1021/bi9617264 · Cited by 220
Self-citationApolipoprotein J and Alzheimer's amyloid β solubility
MATSUBARA, E., SOTO, C., GOVERNALE, S., FRANGIONE, B., & GHISO, J. (1996) · Biochemical Journal · doi:10.1042/bj3160671 · Cited by 190
Self-citationZagorski, M. G., & Barrow, C. J. (1992) · Biochemistry · doi:10.1021/bi00139a028 · Cited by 188
Self-citationLee, J. P., Stimson, E. R., Ghilardi, J. R., Mantyh, P. W., Lu, Y.-A., Felix, A. M., Llanos, W., Behbin, A., Cummings, M., Van Criekinge, M., et al. (1995) · Biochemistry · doi:10.1021/bi00015a033 · Cited by 170
Fibrillogenesis of synthetic amyloid-β peptides is dependent on their initial secondary structure
Soto, C. A., Castaño, E. M., Kumar, R., Beavis, R. C., & Frangione, B. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12089-m · Cited by 161
Self-citationGorevic, P. D., Castaño, E. M., Sarma, R., & Frangione, B. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)91008-4 · Cited by 157
Self-citationFraser, P. E., McLachlan, D. R. C., Surewicz, W. K., Mizzen, C. A., Snow, A. D., Nguyen, J. T., & Kirschner, D. A. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1704 · Cited by 156
Pierpaoli, W., Dall'Ara, A., Pedrinis, E., & Regelson, W. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb16987.x · Cited by 150
Kinetics of aggregation of synthetic β-amyloid peptide
Tomski, S. J., & Murphy, R. M. (1992) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(92)90735-f · Cited by 149
Alpha 1-antichymotrypsin regulates Alzheimer beta-amyloid peptide fibril formation.
Eriksson, S., Janciauskiene, S. M., & Lannfelt, L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.2313 · Cited by 137
Soto, C. A., & Castaño, E. M. (1996) · Biochemical Journal · doi:10.1042/bj3140701 · Cited by 119
Self-citationNaiki, H., Gejyo, F., & Nakakuki, K. (1997) · Biochemistry · doi:10.1021/bi9624705 · Cited by 105
Melatonin in the chicken brain: Its origin, diurnal variation, and regional distribution
Pang, S. F., Ralph, C. L., & Reilly, D. P. (1974) · General and Comparative Endocrinology · doi:10.1016/0016-6480(74)90026-4 · Cited by 75
Fibrillogenesis of Alzheimer Aβ peptides studied by fluorescence energy transfer
Huang, T. H. J., Fraser, P. E., & Chakrabartty, A. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1050 · Cited by 55
Abnormal melatonin response to 5-methoxypsoralen in dementia
Souêtre, E., Salvati, E., Krebs, B., Belugou, J. L., & DARCOURT, G. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.8.1037 · Cited by 26
Ultrastructural evidence that insoluble microtubules are components of the neurofibrillary tangle
Pappolla, M. A., Alzofon, J., McMahon, J. T., & Theodoropoulos, T. J. (1990) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf01735057 · Cited by 16
Self-citation
Cited by
Amyloid Beta: Structure, Biology and Structure-Based Therapeutic Development
Chen, G.-F., Xu, T.-H., Yan, Y., Zhou, Y.-R., Jiang, Y., Melcher, K., & Xu, H. E. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.28 · Cited by 1,965
Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro
Ono, K., Hasegawa, K., Naiki, H., & Yamada, M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20025 · Cited by 1,254
Galano, A., Tan, D. X., & Reiter, R. J. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00916.x · Cited by 1,146
Oxidative damage in the central nervous system: protection by melatonin
Reiter, R. J. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00052-5 · Cited by 838
ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Raulin, A.-C., Doss, S. V., Trottier, Z. A., Ikezu, T. C., Bu, G., & Liu, C.-C. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00574-4 · Cited by 756
Metadata
- Authors
- Pappolla, M., Bozner, P., Soto, C., Shao, H., Robakis, N. K., Zagorski, M., Frangione, B., & Ghiso, J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1998-03
- Volume
- 273
- Issue
- 13
- Pages
- 7185-7188
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2063991495
- Cited by
- 337
- References
- 51
- FWCI
- 8.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.